BlackRock Fund Advisors’s Sonoma Pharmaceuticals SNOA Stock Holding History

BlackRock Fund Advisors’s Portfolio SNOA Stock Details SNOA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$8K	Buy	9 +3	+50%	+$2.49K	﹤0.01%	3994
2016 Q3	$4K	Buy	6 +1	+20%	+$751	﹤0.01%	4104
2016 Q2	$4K	Hold	5	–	–	﹤0.01%	4132
2016 Q1	$4K	Buy	5 +1	+25%	+$929	﹤0.01%	4130
2015 Q4	$4K	Buy	+4	New	+$4.26K	﹤0.01%	4180

Other funds holding SNOA

Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

BRWA

B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return

AIM

Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BlackRock Fund Advisors's SNOA Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Sonoma Pharmaceuticals (SNOA) stake by 50% in Q4 2016, buying an estimated $2.49K and bringing the position to 9 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #3994.

BlackRock Fund Advisors first reported a position in SNOA in Q4 2015 and has held it in 5 quarters since. 21 funds tracked by Wall St. Rank hold SNOA as of Q4 2016.

BlackRock Fund Advisors held 9 shares of Sonoma Pharmaceuticals worth $8K as of Q4 2016.
BlackRock Fund Advisors bought 3 Sonoma Pharmaceuticals shares in Q4 2016, an estimated $2.49K.
Sonoma Pharmaceuticals made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3994 holding.
BlackRock Fund Advisors first reported a position in Sonoma Pharmaceuticals in Q4 2015 and has held it in 5 quarters since.
21 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.